Evolution of hepatic fibrosis and steatosis during long-term use of metformin in patients with type 2 diabetes

被引：0
|
作者：
Lee, Hye Won [1 ]
Kim, Seung Up [1 ]
Lee, Jae Seung [1 ]
Kim, Beom Kyung [1 ]
Park, Jun Yong [1 ]
Kim, Do Young [1 ]
Ahn, Sang Hoon [1 ]
Han, Kwang-Hyub [1 ]
机构：
[1] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea
来源：
JOURNAL OF HEPATOLOGY | 2020年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THU032
引用
收藏
页码：S156 / S157
页数：2
相关论文
共 50 条
  • [31] Low-Grade Hepatic Steatosis Is Associated with Long-term Remission of Type 2 Diabetes Independent of Type of Bariatric-Metabolic Surgery
    Anne Lautenbach
    Marie Wernecke
    Oliver Mann
    Jonas Wagner
    Stefan Wolter
    Fabian Stoll
    Jens Aberle
    Obesity Surgery, 2023, 33 : 530 - 538
  • [32] Long-term treatment study of global standard dose metformin in Japanese patients with type 2 diabetes mellitus
    Odawara M.
    Kawamori R.
    Tajima N.
    Iwamoto Y.
    Kageyama S.
    Yodo Y.
    Ueki F.
    Hotta N.
    Diabetology International, 2017, 8 (3) : 286 - 295
  • [33] HEPATIC-FIBROSIS DURING LONG-TERM METHOTREXATE THERAPY
    RICCIBLUE, P
    GROSS, JB
    MCGILL, DB
    HEPATOLOGY, 1994, 20 (04) : A189 - A189
  • [34] Long-term therapy with addition of pioglitazone to metformin compared with the addition of gliclazide to metformin in patients with type 2 diabetes: a randomized, comparative study
    Matthews, DR
    Charbonnel, BH
    Hanefeld, M
    Brunetti, P
    Schernthaner, G
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2005, 21 (02) : 167 - 174
  • [35] Simulating long-term outcomes of liraglutide plus metformin versus metformin and metformin plus glimepiride in type 2 diabetes patients with inadequate glycaemic control
    Valentine, WJ
    Wittrup-Jensen, KU
    Nicklasson, L
    Roze, S
    Palmer, AJ
    Nauck, MA
    DIABETES, 2005, 54 : A613 - A613
  • [36] The Long-term Effects of Metformin on Patients With Type 2 Diabetic Kidney Disease
    Kwon, Soie
    Kim, Yong Chul
    Park, Jae Yoon
    Lee, Jeonghwan
    An, Jung Nam
    Kim, Clara Tammy
    Oh, Sohee
    Park, Seokwoo
    Kim, Dong Ki
    Oh, Yun Kyu
    Kim, Yon Su
    Lim, Chun Soo
    Lee, Jung Pyo
    DIABETES CARE, 2020, 43 (05) : 948 - 955
  • [37] HEPATIC STEATOSIS AS DIABETES TYPE 2 PREDICTOR
    Loureiro, Carolina
    Martinez-Aguayo, Alejandro
    Campino, Carmen
    Carvajal, Cristian
    Fardella, Carlos
    Garcia, Hernan
    NUTRICION HOSPITALARIA, 2014, 29 (02) : 350 - 358
  • [38] Free fatty acid kinetics during long-term treatment with pioglitazone added to sulfonylurea or metformin in Type 2 diabetes
    Roden, M.
    Mariz, S.
    Brazzale, A. R.
    Pacini, G.
    JOURNAL OF INTERNAL MEDICINE, 2009, 265 (04) : 476 - 487
  • [39] Efficacy of dapagliflozin on hepatic fibrosis and steatosis in patients of type 2 diabetes with non alcoholic fatty liver disease
    Das, S.
    Das, V.
    Prusty, B.
    Agarwal, V.
    Sahoo, D.
    Sahu, S.
    Meher, D.
    Choudhury, A.
    Swain, J.
    DIABETOLOGIA, 2024, 67 : S497 - S497
  • [40] Hepatic Steatosis and Fibrosis Are Significantly Associated with Left Ventricular Diastolic Dysfunction in Elderly Patients with Type 2 Diabetes
    Shin, Sungjae
    Kim, Gyuri
    Lee, Hokyou
    Kim, So Ra
    Lee, Byung Wan
    Kang, Eun Seok
    Ahn, Chul Woo
    Cha, Bong Soo
    Huh, Kap Bum
    Lee, Yong Ho
    DIABETES, 2017, 66 : A410 - A411
12345